Michael J. Brooks - 04 Aug 2023 Form 4 Insider Report for Edesa Biotech, Inc. (EDSA)

Role
President
Signature
/s/ Michael J. Brooks
Issuer symbol
EDSA
Transactions as of
04 Aug 2023
Net transactions value
$0
Form type
4
Filing time
04 Aug 2023, 16:18:59 UTC
Previous filing
24 Jul 2023
Next filing
02 Jun 2025

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction EDSA Common Shares Award +93,200 +306% 123,680 04 Aug 2023 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Reflects a grant of restricted share units ("RSUs"), which vested in full upon grant, pursuant to the Issuer's 2019 Equity Incentive Compensation Plan. These RSUs represent awards received in lieu of a portion of Reporting Person's cash bonus earned for the calendar year ending December 31, 2022. The number of RSUs was determined by dividing such portion of the cash bonus by the 5-day volume weighted average price (VWAP) of the Issuer's common shares through July 31, 2023.